Accelerate Diagnostics Inc (AXDXQ)

Currency in USD
0.0002
-0.0150(-98.68%)
Delayed Data·
AXDXQ Scorecard
Full Analysis
Operates with a significant debt burden
AXDXQ is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.00020.0002
52 wk Range
0.00012.0900
Key Statistics
Prev. Close
0.0152
Open
0.0002
Day's Range
0.0002-0.0002
52 wk Range
0.0001-2.09
Volume
51.27K
Average Volume (3m)
2.01M
1-Year Change
-98.78%
Book Value / Share
-2.24
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AXDXQ Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Accelerate Diagnostics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Accelerate Diagnostics Inc Company Profile

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States and internationally. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing (AST) of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides Accelerate PhenoTest BC Kit, a test kit for the system, which is indicated as an aid, in conjunction with other clinical and laboratory findings, in the diagnosis of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. In addition, the company offers Accelerate Arc system, an instrument and associated one-time-use test kit that automates the clean-up and concentration of microbial cells from positive blood culture samples. Further, it develops Accelerate WAVE system, which performs AST directly from positive blood culture bottles and bacterial isolate colonies to report minimum inhibitory concentrations. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona. On May 8, 2025, Accelerate Diagnostics, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Compare AXDXQ to Peers and Sector

Metrics to compare
AXDXQ
Peers
Sector
Relationship
P/E Ratio
0.0x−13.6x−0.5x
PEG Ratio
0.000.180.00
Price/Book
0.0x2.6x2.6x
Price / LTM Sales
0.0x0.7x3.2x
Upside (Analyst Target)
-86.2%40.5%
Fair Value Upside
Unlock13.1%4.4%Unlock

Earnings

Latest Release
Mar 21, 2025
EPS / Forecast
-0.38 / -0.47
Revenue / Forecast
2.82M / 5.30M
EPS Revisions
Last 90 days

AXDXQ Income Statement

People Also Watch

1.145
GAME
-9.84%
0.973
WINT
-4.61%
0.529
CLSD
-1.80%
5.2245
CLRB
-2.35%
6.580
CAPR
+1.54%

FAQ

What Stock Exchange Does Accelerate Diagnostics Trade On?

Accelerate Diagnostics is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Accelerate Diagnostics?

The stock symbol for Accelerate Diagnostics is "AXDXQ."

What Is the Accelerate Diagnostics Market Cap?

As of today, Accelerate Diagnostics market cap is 5.04K.

What Is Accelerate Diagnostics's Earnings Per Share (TTM)?

The Accelerate Diagnostics EPS (TTM) is -2.15.

From a Technical Analysis Perspective, Is AXDXQ a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Accelerate Diagnostics Stock Split?

Accelerate Diagnostics has split 2 times.

How Many Employees Does Accelerate Diagnostics Have?

Accelerate Diagnostics has 107 employees.

What is the current trading status of Accelerate Diagnostics (AXDXQ)?

As of 25 Jul 2025, Accelerate Diagnostics (AXDXQ) is trading at a price of 0.00, with a previous close of 0.02. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 2.09.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.